[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f2lGU5q0b3qjgnuX5t3etlJ19Y3f-d8movGkHE6DW4ZI":8,"$fa_9ifs2NFIosSnmxTVv2PU-LhrP0wRS69xvljAqrDDM":55,"$f38ISv73mQv5ldBf0daWTgmQCTrYWRZY_uXCMfDcxmPU":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67334,869602,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//0qXGHITNAdXR19Vz0pQyKQd9rTWoq88X.png","周中成","嘉兴市第二医院","肝胆外科","副主任医师",11,0,"胰腺癌IV期肝转移化疗：AG方案用药与副作用安全指南","","https://ystcdn.venuertc.com/venue/AI/644da7e8-9c99-4954-b915-428b193d1709.jpg","\u003Cdiv class=\"ag-material-container\">\n  \u003Ch2 id=\"material_title\" class=\"ag-material-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">胰腺癌IV期肝转移化疗：AG方案用药与副作用安全指南\u003C/h2>\n\n  \u003Cdiv class=\"ag-material-lead\" style=\"font-size:18px;margin:24px 0 32px 0;\">\n    说到化疗药物，吉西他滨和白蛋白结合型紫杉醇（AG方案）是许多医院常用的静脉给药组合。它们主要被用于多种肿瘤治疗场景。本文将带你了解这两种药品的关键用药细节、常见副作用、用法用量、储存方式、可能的药物相互作用，以及出现不良反应时的应对措施。共梳理出7大用药点，每一处都关乎安全与疗效。\u003Cspan style=\"font-size:24px;vertical-align:middle;\">💊\u003C/span>\n  \u003C/div>\n\n  \u003C!-- 01 AG方案成分与剂型特点 -->\n  \u003Cdiv class=\"ag-material-section\">\n    \u003Ch2 class=\"ag-material-subtitle\" style=\"background: linear-gradient(90deg, rgb(248, 250, 252) 60%, rgb(224, 234, 249) 100%); padding: 12px 18px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 AG方案的成分和剂型特点\u003C/h2>\n    \u003Cdiv class=\"ag-material-content\">\n      AG方案主要由两种药品组成：\u003Cb>吉西他滨\u003C/b>（Gemcitabine）和\u003Cb>白蛋白结合型紫杉醇\u003C/b>（Nab-paclitaxel）。两者都是以注射剂为主，通过静脉滴注给药。\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>\u003Cb>吉西他滨：\u003C/b>属于抗代谢类药物，规格通常为200 mg、1000 mg注射用冻干粉。需配合氯化钠注射液稀释后使用。\u003C/li>\n        \u003Cli>\u003Cb>白蛋白结合型紫杉醇：\u003C/b>属于天然产物抗肿瘤药，规格以100 mg注射用冻干粉为主。使用前同样需要稀释。\u003C/li>\n      \u003C/ul>\n      \u003Cspan style=\"font-size:22px;\">🧪\u003C/span>\n      \u003Cb>剂型特点：\u003C/b>\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>均为静脉注射剂型，不能口服。\u003C/li>\n        \u003Cli>稀释过程由专业医护人员完成。\u003C/li>\n        \u003Cli>药液需即配即用，不建议长时间放置。\u003C/li>\n      \u003C/ul>\n      \u003Cb>正确做法：\u003C/b>始终由有经验的护士或医生进行药物配制和输注，避免自行处理药液。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 02 药品作用机制及优势 -->\n  \u003Cdiv class=\"ag-material-section\">\n    \u003Ch2 class=\"ag-material-subtitle\" style=\"background: linear-gradient(90deg, rgb(240, 247, 238) 60%, rgb(243, 233, 227) 100%); padding: 12px 20px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药品作用机制简介与方案优势\u003C/h2>\n    \u003Cdiv class=\"ag-material-content\">\n      \u003Cb>药品如何发挥作用？\u003C/b>\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>\u003Cb>吉西他滨：\u003C/b>能阻止细胞DNA合成，抑制癌细胞分裂。\u003C/li>\n        \u003Cli>\u003Cb>白蛋白结合型紫杉醇：\u003C/b>通过稳定微管结构，干扰癌细胞分裂。\u003C/li>\n      \u003C/ul>\n      \u003Cspan style=\"font-size:21px;\">🔬\u003C/span>\n      不同于单药治疗，AG方案联合使用能增强药效。临床数据显示，AG方案在部分用药场景下的有效率高于吉西他滨单药（Von Hoff DD et al., 2013）。\n      \u003Cdiv class=\"ag-material-data\">\n        \u003Cb>数据表明：\u003C/b>一项多中心试验显示，AG方案的总反应率达到23%，而吉西他滨单药约为7%。\u003Cbr>\u003Cspan style=\"font-size:16px;color:#999;\">(参考文献见文末)\u003C/span>\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 03 AG方案用法用量及服药注意事项（避免与机制重复） -->\n  \u003Cdiv class=\"ag-material-section\">\n    \u003Ch2 class=\"ag-material-subtitle\" style=\"background: linear-gradient(90deg, rgb(255, 247, 231) 60%, rgb(229, 247, 250) 100%); padding: 12px 20px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 用法用量及周期安排\u003C/h2>\n    \u003Cdiv class=\"ag-material-content\">\n      \u003Cb>具体用法：\u003C/b>\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>AG方案采用21天为一个治疗周期。\u003C/li>\n        \u003Cli>第1天、第8天、第15天静脉滴注吉西他滨与白蛋白结合型紫杉醇，随后休息一周（第16-21天不用药）。\u003C/li>\n        \u003Cli>滴注时间一般为30-180分钟，由医生根据耐受情况调整。\u003C/li>\n      \u003C/ul>\n      \u003Cb>用量调整：\u003C/b>\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>剂量通常按体表面积（m\u003Csup>2\u003C/sup>）计算，每次需专业医生根据患者体重和肝肾功能评估后决定。\u003C/li>\n        \u003Cli>老年患者或体力较弱者，常需要减量。\u003C/li>\n      \u003C/ul>\n      \u003Cspan style=\"font-size:20px;\">⏰\u003C/span>\n      \u003Cb>正确做法：\u003C/b>\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>严格按照医生制定的周期与剂量给药。\u003C/li>\n        \u003Cli>滴注前后6小时避免进食刺激性及含酒精饮料。\u003C/li>\n        \u003Cli>治疗期间定期复查肝肾功能与血常规。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"ag-material-case\" style=\"margin-top:8px;color:#3a7be3;\">\n        案例示例：一名64岁女性患者在每周期第1、8、15天接受标准剂量配置后，因体重偏低，医生调整剂量，实现个体化给药。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 04 药物相互作用与用药注意事项 -->\n  \u003Cdiv class=\"ag-material-section\">\n    \u003Ch2 class=\"ag-material-subtitle\" style=\"background: linear-gradient(90deg, rgb(249, 238, 246) 60%, rgb(246, 248, 250) 100%); padding: 12px 18px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药品相互作用与并用注意重点\u003C/h2>\n    \u003Cdiv class=\"ag-material-content\">\n      化疗期间，AG方案涉及多种药物并用。关键需警惕以下几类情况：\n      \u003Cb>常见药物相互作用：\u003C/b>\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>紫杉醇类与抗真菌药（如酮康唑）并用时，可能增强紫杉醇毒性。\u003C/li>\n        \u003Cli>吉西他滨与华法林等抗凝药共同应用时，需密切监测凝血功能。\u003C/li>\n        \u003Cli>部分降压、降糖药可能因肝酶竞争，影响化疗药代谢。\u003C/li>\n      \u003C/ul>\n      \u003Cspan style=\"font-size:20px;\">⚠️\u003C/span>\n      \u003Cb>正确做法：\u003C/b>\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>用药期间如需合并其他药品，务必提前告知医生所有用药史。\u003C/li>\n        \u003Cli>不推荐自行增加、减少或停用任何药品。\u003C/li>\n        \u003Cli>避免饮酒及服用草药成分不明确的补品。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"ag-material-case\" style=\"margin-top:8px;color:#c92444;\">\n        临床上，曾有患者因与降压药合用后出现不良反应，经及时沟通调整后避免风险。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 05 AG方案常见不良反应及识别处理 -->\n  \u003Cdiv class=\"ag-material-section\">\n    \u003Ch2 class=\"ag-material-subtitle\" style=\"background: linear-gradient(90deg, rgb(247, 249, 234) 60%, rgb(232, 242, 252) 100%); padding: 12px 18px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 常见不良反应及处理方法\u003C/h2>\n    \u003Cdiv class=\"ag-material-content\">\n      AG方案化疗药品副作用较多，类型丰富。下列情况较为常见：\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>\u003Cb>消化道反应：\u003C/b>恶心、呕吐、腹泻、便秘。\u003C/li>\n        \u003Cli>\u003Cb>骨髓抑制：\u003C/b>白细胞、血小板、红细胞减少。\u003C/li>\n        \u003Cli>\u003Cb>肝肾功能损伤：\u003C/b>转氨酶升高或肌酐升高。\u003C/li>\n        \u003Cli>\u003Cb>神经毒性：\u003C/b>手脚麻木、刺痛感。\u003C/li>\n        \u003Cli>\u003Cb>过敏反应：\u003C/b>皮疹、瘙痒、输注时呼吸急促。\u003C/li>\n        \u003Cli>\u003Cb>罕见不良反应：\u003C/b>间质性肺炎等。\u003C/li>\n      \u003C/ul>\n      \u003Cspan style=\"font-size:21px;\">🚨\u003C/span>\n      \u003Cb>出现不良反应时：\u003C/b>\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>轻度消化症状可对症处理（如服用止吐药）。\u003C/li>\n        \u003Cli>骨髓抑制：每周抽血监测，必要时暂停化疗或使用升白/升血药物。\u003C/li>\n        \u003Cli>肝肾损伤：暂停化疗并用保肝/护肾药。\u003C/li>\n        \u003Cli>神经症状：减少紫杉醇剂量或短期停用，合并营养神经药。\u003C/li>\n        \u003Cli>过敏：视症状予以抗过敏药物，严重时立即停药。\u003C/li>\n        \u003Cli>间质性肺炎：每期复查胸部CT，发现异常即停药。\u003C/li>\n      \u003C/ul>\n      \u003Cb>何时需要医生处理？\u003C/b>\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>体温升高、持续呕吐、黄疸、呼吸困难等情况，需立即联系医生。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"ag-material-data\">\n        临床数据显示，AG方案导致3级以上骨髓抑制的比例约为38%（Von Hoff DD et al., 2013）。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 06 储存方式与有效期管理 -->\n  \u003Cdiv class=\"ag-material-section\">\n    \u003Ch2 class=\"ag-material-subtitle\" style=\"background: linear-gradient(90deg, rgb(247, 243, 255) 60%, rgb(230, 253, 243) 100%); padding: 12px 20px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 储存条件与药品有效期管理\u003C/h2>\n    \u003Cdiv class=\"ag-material-content\">\n      \u003Cb>正确储存方法：\u003C/b>\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>吉西他滨、白蛋白结合紫杉醇均应密封储存于2-8°C冰箱内。\u003C/li>\n        \u003Cli>避免阳光直射和高温。\u003C/li>\n        \u003Cli>稀释配制后的药液应在6小时内用完。\u003C/li>\n      \u003C/ul>\n      \u003Cspan style=\"font-size:20px;\">📦\u003C/span>\n      \u003Cb>过期药品处理：\u003C/b>\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>过期药品必须交由医院或指定药品回收点处理，不能随意丢弃。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"ag-material-tip\" style=\"color:#fa9300;\">\n        储存温度不当会影响药品疗效，特别是夏季断电或外运需专用冷箱。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 07 漏服与过量应对办法 -->\n  \u003Cdiv class=\"ag-material-section\">\n    \u003Ch2 class=\"ag-material-subtitle\" style=\"background: linear-gradient(90deg, rgb(255, 249, 240) 60%, rgb(241, 248, 250) 100%); padding: 12px 18px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 漏服与过量情况的应对措施\u003C/h2>\n    \u003Cdiv class=\"ag-material-content\">\n      \u003Cb>AG方案由于为静脉滴注，漏服主要表现为漏掉某一次化疗：\u003C/b>\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>如因身体不适错过某一次化疗，需由医生根据情况安排补做或调整剂量。\u003C/li>\n        \u003Cli>不可自行更改治疗计划或一次性补足两次治疗。\u003C/li>\n        \u003Cli>过量滴注或误配药液要立即报告，由医生根据具体情况进行解救及支持治疗。\u003C/li>\n      \u003C/ul>\n      \u003Cspan style=\"font-size:19px;\">⛑️\u003C/span>\n      \u003Cb>正确做法：\u003C/b>\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>严格遵循医嘱，每次化疗做好记录。\u003C/li>\n        \u003Cli>出现误用、过量、身体严重不适时，最快速度联系化疗团队。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"ag-material-case\" style=\"margin-top:8px;color:#7ab737;\">\n         临床指导建议：有患者错过第15天化疗，经医生调整方案延长休息时间，未造成明显副作用加重。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 08 特殊人群用药调整 -->\n  \u003Cdiv class=\"ag-material-section\">\n    \u003Ch2 class=\"ag-material-subtitle\" style=\"background: linear-gradient(90deg, rgb(246, 246, 246) 60%, rgb(239, 247, 250) 100%); padding: 12px 18px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 特殊人群用药：老年人与肝肾功能受损者\u003C/h2>\n    \u003Cdiv class=\"ag-material-content\">\n      \u003Cb>用药调整原则：\u003C/b>\n      \u003Cul class=\"ag-material-list\">\n        \u003Cli>老年患者或体重偏低人群，通常根据耐受情况减量，避免骨髓抑制。\u003C/li>\n        \u003Cli>肝肾功能受损者应进行动态监测、必要时降剂量或延长周期。\u003C/li>\n        \u003Cli>妊娠及哺乳期女性不建议使用此方案。\u003C/li>\n      \u003C/ul>\n      \u003Cspan style=\"font-size:18px;\">🧑‍🦳\u003C/span>\n      正确做法：所有特殊人群用药必须在医生指导下个体化调整，不建议照搬标准剂量。\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 09 总结与安全提醒 -->\n  \u003Cdiv class=\"ag-material-summary\" style=\"margin:30px 0 24px 0;background:#faf8f2;padding:18px 20px;border-radius:12px;\">\n    \u003Ch2 class=\"ag-material-summary-title\" style=\"font-size: 22px; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🔎 核心用药要点总结\u003C/h2>\n    \u003Cul class=\"ag-material-list\">\n      \u003Cli>AG方案化疗药品仅可静脉滴注，不可用于口服/皮下注射。\u003C/li>\n      \u003Cli>每周期三次给药，严格遵循时间、剂量要求。\u003C/li>\n      \u003Cli>多药合用需谨防相互作用，主动告知医生全部用药史。\u003C/li>\n      \u003Cli>常见副作用包括骨髓抑制、消化道反应等，出现异常及时处理。\u003C/li>\n      \u003Cli>药品需低温保存，配制后尽快用完，不使用过期药品。\u003C/li>\n      \u003Cli>漏服、过量均不可自作主张调整，务必联系专业团队。\u003C/li>\n      \u003Cli>老年、肝肾功能受损等特殊人群用药必须个体化。\u003C/li>\n    \u003C/ul>\n    \u003Cb>特别提醒：\u003C/b>安全用药是化疗疗效的保障。如果疑问或不适，请咨询专业医生。\u003Cspan style=\"font-size:22px;color:#e95b31;\">🛡️\u003C/span>\n  \u003C/div>\n\n  \u003C!-- 10 参考文献 -->\n  \u003Cdiv class=\"ag-material-ref\" style=\"background:#edf3fc;padding:10px 16px;border-radius:10px;\">\n    \u003Ch3 class=\"ag-material-ref-title\" style=\"font-size: 17px; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献 | References\u003C/h3>\n    \u003Cul style=\"font-size:15px;line-height:2.0;\">\n      \u003Cli>Von Hoff, D. D., Ervin, T., Arena, F. P., et al. (2013). Increased Survival in Pancreatic Cancer with nab-Paclitaxel Plus Gemcitabine. \u003Ci>New England Journal of Medicine, 369\u003C/i>(18), 1691-1703. \u003Cb>doi:10.1056/NEJMoa1304369\u003C/b>\u003C/li>\n      \u003Cli>Okusaka T, Nakachi K, et al. (2020). Current status of treatment for pancreatic cancer: From chemotherapy to the latest knowledge. \u003Ci>World Journal of Gastroenterology, 26\u003C/i>(27), 4013-4020. \u003Cb>doi:10.3748/wjg.v26.i27.4013\u003C/b>\u003C/li>\n      \u003Cli>National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma. Version 1.2024. \u003Cb>www.nccn.org\u003C/b>\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.ag-material-container {\n  font-family: \"PingFang SC\",\"Microsoft YaHei\",Arial,Helvetica,sans-serif;\n  background: #f7f7fb;\n  color: #333;\n  max-width:820px;\n  margin: 24px auto;\n  border-radius:12px;\n  box-shadow:0 4px 16px rgba(40,54,123,0.06);\n  padding: 28px 26px 24px 26px;\n}\n.ag-material-title {\n  font-size: 32px;\n  font-weight: bold;\n  color: #162d6b;\n  text-align: center;\n  margin: 0 0 24px 0;\n  letter-spacing: 1.4px;\n}\n.ag-material-lead {\n  background: #e7f9fa;\n  border-left: 8px solid #80e3e0;\n  border-radius:10px;\n  padding:20px 20px 16px 28px;\n}\n.ag-material-section {\n  margin: 32px 0 0 0;\n  border-radius:10px;\n  box-shadow:0 0 0 #fff;\n}\n.ag-material-subtitle {\n  font-size:23px;\n  font-weight:bold;\n  margin-bottom:12px;\n  border-radius:8px 8px 0 0;\n  background-size:contain;\n  color:#27427a;\n  letter-spacing:0.5px;\n}\n.ag-material-content {\n  padding:18px 22px;\n  font-size:18px;\n  background:#fff;\n  border-radius:0 0 10px 10px;\n  box-sizing:border-box;\n  box-shadow:0 2px 8px rgba(140,170,255,.03);\n}\n.ag-material-list {\n  padding-left:22px;\n  margin:10px 0 10px 0;\n  font-size:17px;\n  color:#232c48;\n}\n.ag-material-case {\n  font-size:15px;\n  background:#ebf6fa;\n  border-left:4px solid #b8e7ed;\n  border-radius:7px;\n  padding:7px 13px 7px 16px;\n  margin:13px 0 0 0;\n}\n.ag-material-data {\n  font-size:16px;\n  background:#f4f7f4;\n  border-left:4px solid #b8e7c7;\n  border-radius:7px;\n  padding:7px 13px 7px 16px;\n  margin:13px 0 0 0;\n  color:#23895a;\n}\n.ag-material-tip {\n  font-size:15px;\n  background:#fff6e6;\n  border-left:4px solid #fad692;\n  border-radius:7px;\n  padding:7px 13px 7px 16px;\n  margin:13px 0 0 0;\n}\n.ag-material-summary {\n  margin-top:36px;\n}\n.ag-material-summary-title {\n  color:#184175;\n}\n.ag-material-ref {\n  margin-top:28px;\n}\n.ag-material-ref-title {\n  color:#27427a;\n}\n@media (max-width:620px){\n  .ag-material-container{padding:11px 6px 12px 6px;}\n  .ag-material-title{font-size:24px;}\n  .ag-material-lead{padding:12px 8px 10px 13px;}\n  .ag-material-content{padding:11px 5px;}\n}\n\u003C/style>\n","\u003Cdiv class=\"ag-material-container\">\n  \u003Ch2 id=\"material_title\" class=\"ag-material-title\" style=\"color",545,"2025-09-26 17:20:51","胰腺癌, 化疗, 吉西他滨, 紫杉醇, 副作用, 用药安全, 肝转移, AG方案","了解吉西他滨与白蛋白结合型紫杉醇的用药细节及副作用。针对胰腺癌患者，提供专业的化疗指导，保障安全与疗效。","2025-10-21 12:04:35",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]